Quote:
Originally Posted by Bagor
Lack of transparency is my issue.
For what reason given the now stated obvious benefits being touted by PHAC (boosted immune system and suggested increased protection against any variations of the virus) and the "claimed" safety data from Europe over years past hasn't it been approved by them before?
Surely it could have lowered costs and saved lives in seasons past?
What was their concern with it previously and how has this been addressed?
|
My understanding is that having the adjuvant means that less of the vaccine is required. So that means more doses available.
Quote:
|
Is it that the adjuvant allows for muliple production in a high demand year when compared to the un-adjuvanted form that has allowed it to be rushed through?
|
I dunno, is it?
Quote:
|
Why has the US failed to approve it given that they have declared a national emergency and are experiencing a shortage?
|
Because they don't usually have adjuvanted vaccines? What other reasons are you thinking?